This inventor holds 1 USPTO granted patent. Top assignee: Chemo-Sero-Therapeutic Research Institute. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Syoji Kuzuhara: Innovator in Vaccine Development
Introduction
Syoji Kuzuhara is a notable inventor based in Houtaku, Japan. He has made significant contributions to the field of vaccine development, particularly in the area of hepatitis vaccines. His innovative work has led to the creation of a combined adjuvanted vaccine that addresses both hepatitis A and B.
Latest Patents
Kuzuhara holds a patent for a hepatitis A and B combined adjuvanted vaccine. This vaccine comprises an inactivated hepatitis A virus antigen, a hepatitis B virus surface antigen, and an adjuvant. The unique formulation allows for the antigens to be adsorbed to the adjuvant, preventing interference between the two antigens and minimizing severe side effects. The vaccine significantly enhances the anti-hepatitis A virus antibody titer through this innovative mixing.
Career Highlights
Syoji Kuzuhara is associated with the Juridical Foundation the Chemo-sero-therapeutic Research Institute, where he has been instrumental in advancing vaccine research. His work has been pivotal in developing effective solutions for preventing hepatitis infections.
Collaborations
Kuzuhara has collaborated with notable colleagues, including Koichi Odo and Kyosuke Mizuno. Their combined expertise has contributed to the success of their research initiatives.
Conclusion
Syoji Kuzuhara's contributions to vaccine development, particularly through his patented hepatitis A and B combined adjuvanted vaccine, highlight his role as an innovator in the field. His work continues to impact public health positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile